Introduction
Bacteriophages (phages) are today hypothesized as one of the possible alternatives to antibiotics in animal therapy, prophylaxis and reduction of pathogen loads in food products of animal origin. Trials with bacteriophages and farm animals have proven successful and used to kill foodborne pathogen such as: Escherichia coli (Smith and Huggins environment (Fiorentin et al. 2005; O'Flynn et al. 2006; Atterbury et al. 2007; Higgins et al. 2008) . However, there are many issues that need to be addressed. Firstly, as a rule, it is not possible to isolate a single phage capable to lyse all strains of a particular bacterial species. The use of wide host range phages could be a hypothesis; however, in practice, these phages will loose their usefulness after several applications because of the emergence of phageresistant bacterial mutants. There are also ideas of using hosts, such as safe industrial E. coli strains, for the production of phages but this also presents practical disadvantages as the phages capable to overcome interspecies barriers are rare and this makes it practically impossible to gather a large enough collection of such phages to compose different phage cocktails. Thus, it will be always necessary to use different pathogen strains, isolated in the course of real endemics or infection, for the isolation and production of phage products and cocktails.
Additionally, for some food pathogens, such as Salmonella, choices of basic hosts among the strains are required because of a wide occurrence of the restrictionmodification systems. These basic hosts must be nonlysogenic, and the total collection of isolates needs to be always checked. Also, the use of basic hosts should optimally result in a good output of the phage.
Finally, there are also some general requirements for phages to be selected as therapeutic agents, as for instance: phages must be lytically active for the largest number of bacterial strains isolated from the specific areas, and they must be capable of cross lysing ⁄ killing the phage-resistant variants of each other.
Phage therapy is generally recognized as safe (Bruttin and Brussow 2005; Xie et al. 2005) , but this assumption cannot be accepted without detailed studies, especially when considering the use of live therapeutic phages for long term purposes. So, it is once more emphasized that for a safe use of phages, the ones capable to lysogenize bacterial strains or which have DNA homologies with the chromosome of bacterial hosts are not acceptable.
Salmonella causes acute enteric infections in humans, and the main routes of transmission of this zoonotic bacteria to humans are because of the consumption of contaminated poultry products (eggs, meat) (Lee 1974; Hird et al. 1993; Henzler et al. 1994; Bryan and Doyle 1995) . Poultry carcasses become contaminated with pathogens when a contaminated flock is processed on the slaughter line (Mead et al. 1995) . Thus, the control of Salmonella infections at the farm and processing level is crucial, and the adoption of efficient eradication procedures can decrease the transmission of Salmonella to humans reducing infections and hospitalizations. This work describes the isolation, characterization and selection of suitable Salmonella phages for phage therapy.
Materials and methods

Bacterial strains
Thirty-one Salmonella Enteritidis strains isolated from contaminated food products in Portugal and from poultry farms in England were used for phage isolation and phage lytic spectrum assessment. Also, seven additional strains from the Regensburg strain collection (Germany) were used in the blot hybridization studies. All strains used (Table 1) were grown at 37°C on LB broth or LB agar (Miller 1972) .
Collection bacteriophages
Several Salmonella bacteriophages were provided by the laboratory of bacteriophage genetics (State Research Institute for Industrial Microorganisms, Moscow, Russia), and phage Felix01 was from the Profos AG collection (Regensburg, Germany) ( Table 2) .
Verification of bacterial strains for presence of intact temperate phages
Semi-solid (0AE6%) LB agar with 50 ll of fresh suspension of the tested strains was brought on the Petri Dishes with a layer of normal agarized (1AE2%) LB medium. The drops of the same bacteria (after treatment with CHCl 3 and successive centrifugations to remove bacterial debris and CHCl 3 ) were placed on the lawns. After overnight incubation, the presence of phage lysis zones or other features of possible lysis (e.g. bacteriocins) were evaluated in the drops.
Isolation of new bacteriophages
An enrichment procedure was used for bacteriophage isolation. Briefly, the enrichment culture flasks (0AE5 l) contained 50 ml of 5· concentrated LB nutrient medium, 200 ml of aqueous sample and a mixture of all nonlysogenic S. Enteritidis strains. The bacterial mixture was prepared by growth of the Salm. Enteritidis strains, overnight and at 37°C, on agarized LB medium Petri dishes (15 g of agar per litre of medium). Afterwards, two loops of each different strain were placed into Eppendorf tubes with 1 ml of 0AE9% NaCl, and the tubes were vortexed 1-2 min. Five Hundred microlitres of each of the prepared strain suspensions were mixed in a glass tube. The mixture (0AE5 ml) was used to infect culture flasks containing different samples, and the flasks were incubated overnight at 37°C on shaker (c. 250-400 rev min )1 ). After incubation, 1AE5 ml samples were taken from each of the flasks into Eppendorf tubes, vortexed with the addition of 30 ll of CHCl 3 , centrifuged 2-3 min (12 000 rev min )1 )
to sediment bacterial cells, and debris and drops were placed on the plates with lawns of the tested bacterial strains. After overnight incubation at 37°C, material was taken from the lysis spots and was plated on separate plates with the same bacteria performing dilutions up to , uB2 SE5, u22, u62, u44, u79, u105, u147, u162, u164, u171, u177 Phage collection of the State Research Institute for Industrial Microorganisms, Moscow, Russia u68, u81
Faeces from Poultry farm 1, Braga, Portugal u169, u111
Faeces from Poultry farm 2, Braga, Portugal u31(u31m, u31tu), u38, u39, u135 (u135lar, u135sm), u45 Raw sewage, wastewater treatment plant, Braga, Portugal u2 (u2a, u2b) Zoo pond, Moscow, Russia u12 (u12ht)
Nests from a Poultry farm, Santiago de Compostela, Spain u2 ⁄ 2, u4 ⁄ 1(u4 ⁄ 1a, u4 ⁄ 1b), RBS cl, RBS tu, uS151, uA1, uN5, uN4 Wastewater treatment plant, Regensburg, Germany single plaques could be seen. Phages with reproducible plaque type features were reisolated from a single plaque and plated for confluent lysis (Adams 1959 ) on several Petri dishes. After overnight incubation, the phage was gathered, processed as usual vortexing, centrifugation at 6000 g, 30 min at 4°C, CHCl 3 treatment and kept in refrigerator.
The new isolated bacteriophages were designated: RBS cl, RBS tu, phi 4 ⁄ 1a, phi 4 ⁄ 1b, phi 2 ⁄ 2, phiN4, phiN5, phi A1, phiB1 SE5, phiB2 SE5 (Table 2) .
Purification and concentration of phages in CsCl preformed gradients
Purification and concentration of phages were accomplished as described by Sambrook and Russell (2001) . Phages sensitive to CsCl treatment were concentrated by precipitation with polyethylene glycol (PEG) ⁄ NaCl (Yamamoto et al. 1970 ) with the subsequent sedimentation, resuspension in phage buffer SM (Sambrook and Russell 2001) and at least two additional cycles of washing by sedimentation and resuspension. Such preparations were treated with exonuclease (10 mcg l )1 , 1 h at 37°C) to disrupt bacterial DNA and centrifuged 3 h at 40 000 g to sediment the phage. Finally, phage pellet was resuspended in SM buffer.
Isolation of phage DNA, treatment of DNA with endonucleases, electrophoresis, Southern hybridization
These procedures were performed as described in Sambrook and Russell (2001) .
Antibiotic susceptibility test
The susceptibility of the 31 Salm. Enteritidis isolates to eight antimicrobial agents was determined by the disc diffusion method on modified Mueller Hinton II agar according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). The antimicrobial agents and the respective concentrations (in micrograms) used are shown in Table 1 . The results were interpreted according to established criteria by the EUCAST (http:// eucast.www137.server1.mensemedia.net/)
Results
This works aim at grouping the isolated phages as a first step for their classification and at studying the homology between the DNA, the different phages and bacterial hosts genomes to exclude all phages capable of enhancing recombination promoting inclusion into the bacterial genome genes, which could code pathogenic products.
These are compulsory experiments that need to be performed to verify phage safety and to select suitable candidates for therapeutic purposes.
Isolation of phages
Verification of production of intact temperate phages by the bacterial target hosts To isolate phages, it was necessary to exclude from the enrichment experiments evident lysogens, otherwise the host's temperate phage(s) would interfere with the interpretation of the results. All 25 Portuguese strains were checked, and the different strains did not reveal live temperate phages. Thus, for isolation of new phages, all these strains were mixed and used together in the enrichment experiments. It was necessary to ensure that the strains used in the isolation procedure were different. For that all hosts, isolated from either contaminated foods or animals (poultry), were tested for their susceptibility towards eight antibiotics. Based on the antibiotic susceptibility patterns, the isolates were grouped into nine distinct clusters (Table 1) . Furthermore, the UK isolates have been previously characterized (Cooper et al. 1994; Cogan et al. 2004) , and therefore their phage type was included in Table 1 .
Selection of phages after enrichment procedure
The bacteriophages used in this work were isolated from different environments and countries (Table 2 ). All phages with different plaque types were repeatedly plated to assure their phenotype stability and phage plaque parameters such as size, turbid ⁄ clear appearance, edge morphology, presence of halo around plaques, growth of phage-resistant bacterial colonies in the lysis spot and estimation of their number were studied (data not shown). Phages with the best plaque parameters (clear appearance and the smallest number of phage-resistant colonies) were chosen for detailed studies (see bold in Table 2 ). Interestingly, the strains used in this work were shown to be highly sensitive to most of the phages. In fact, the only strain studied that was resistant to all selected phages was strain 392.
General comparison of single selected phages on the basis of their primary features: plaque phenotypes and the growth on different strains in collection In this work, a mixture of all nonlysogenic hosts were used to isolate new phages, to evaluate the effect of the phage propagation host on the host range, to differentiate potentially genotypically different phages and include them in further studies.
Optimal hosts for each potentially different phage were thus selected, in the course of comparison of phage growth on different hosts, and the strain which supported the phage growth in the best way (larger plaque size, higher transparency, small number of resistant variants) was accepted as an optimal host for that particular phage (data not shown). Also, in comparison with the quality of phage growth on different hosts, optimal bacterial strains capable to support the growth of as many as possible phages in the collection were chosen. An additional feature which was used to select and differentiate phages was their plaque appearance. According to the results of this work, the best strains for differentiation of the phages used were Ex2 and 9510 (both from the University of Bristol collection).
Differentiation of the selected phages with RFLP profiles
To have comparable results of the phage RFLPs, most of the restriction experiments were performed with EcoRV endonuclease. To simplify the interpretation of results, they were grouped in several independent experiments.
The DNA digestions of several Salmonella phages were performed (Figs 1, 2 and 3). The DNA of six digested phages revealed nonidentical RFLP profiles and phage u31m showed to be resistant to EcoRV (Fig. 1) . However, there were some evident similarities between these six phages and their genome sizes, calculated as sums of the molecular weights of the restrictional fragments, which varied between 32 and 38 kb. Thus, it can be suggested that the six EcoRV digested phages, namely u135lar, u135sm, u38, u169, u68 and u39, may belong to the same phage group (group 1) while u31m belongs to a different group.
Phages u2 and u4 ⁄ 1 produced morphologically different plaques on their hosts. Therefore, digestions of the DNA of the two specific variants of each phage (u2a, u2b, u4 ⁄ 1a and u4 ⁄ 1b) were performed (Fig. 2a) . The digestion profile differed considerably from the ones obtained after EcoRV digestion of the six phages belonging to phage group 1 (compare Figs 1 and 2a) . Therefore, u2 and u4 ⁄ 1 phages are unrelated from the phages of group 1 and may be considered as presenting two additional phage groups, groups 2 and 3, respectively. Both variants of each group, a and b respectively, have a similar restriction profile showing a great number of bands. Despite the morphological plaque dissimilarity between the two phage variants (a and b) of each phages u2 and u4 ⁄ 1, their RFLP profiles cannot be differentiated (Fig. 2a) . In this work, a high titre of phage u12 preparation was purified, concentrated by treating with PEG (see Materials and methods) and afterwards treated with DNase. After DNase removal by sedimentation, the DNA was isolated either directly from the lysate (u12L) or from the single band obtained after CsCl centrifugation (u12P). As possible to observe (Fig. 2b) , there was a great difference in the RFPL profiles of both DNAs. Most of the restriction fragments found in the DNA of phage preparation u12 in the lysate disappeared after CsCl centrifugation (Fig. 2b) . Also, phage u12 is different from the other phages and therefore belongs to a different group (group 4). Phage u2 ⁄ 2 DNA digestion with HindIII was performed after the growth of this phage on two distinct hosts (1400 and Ex2) (Fig. 3) . Phage u2 ⁄ 2 has the biggest genome among the studied phages which was c. 92-94 kb as calculated by summing the sizes of the restrictional fragments. Phage u2 ⁄ 2 grown in both strains, resulted in equivalent digestions without additional nonequimolar fragments. Thus, this phage is different from the other ones found belonging to groups 1-4 and therefore belong to a new group (group 5).
Besides the DNA of u31m, the DNAs of three other phages u31tu, uN5 and uA1 were also shown to be resistant to both EcoRV and EcoRI (data not shown). Thus, these phages may provisionally be considered as different from the other groups of phages. However, they cannot be grouped together without further characterization.
Estimation of DNA homology between the selected phages and between phages and their target bacterial strains
Homology studies of three different phages were performed. The phages used were phages u169 (group 1), u4 ⁄ 1 (group 3) and u31tu (so far unassigned group), respectively. From the studied phages, the DNAs of u169 and u31tu did not show homology with bacterial DNA in the dot blots (data not shown). The dot blot-hybridization of P 32 labelled u169 DNA (as zond) with bacterial and other Salmonella phages DNA was performed (Fig. 4) . According to results obtained, phage u169 revealed DNA homology with nine other phages as observed by the presence of plaques in the spots of u68, u39, u135, u38, u2, u45, u79, u81 and u111 but no relation with other phages.
DNA hybridization of P 32 labelled DNA of phage u31tu showed no homology with bacterial DNAs, but revealed a good homology with phage uN5 and a trace of homology with phage u4 ⁄ 1. Furthermore, there was no homology with any other phages (data not presented).
The hybridization of P 32 labelled DNA of phage u4 ⁄ 1 with DNAs of other phages revealed homology with phages uRBSc1 and uA1 (Fig. 5) . It was also observed a weak DNA homology of u4 ⁄ 1 with DNAs of several of the tested bacterial strains (data not shown). This may suggest that phage u4 ⁄ 1 has a higher general input for defective prophages that are capable to be packed in the phage particles than all other studied phages. Thus, phage u4 ⁄ 1 may be considered as a virulent mutant of a temperate phage, and it has DNA homology with some M f 2/2.S f 2/2.Ex2 1400 Figure 3 HindIII digestion of Salmonella phage u2 ⁄ 2 DNA grown on Salmonella Enteritidis strains 1400 and Ex2. Lane M -k HindIII molecular weight marker.
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defective prophage(s), possibly with phage P22 of lambda group that are common in some of the Salmonella strains of the studied collection. The RFLP profile studies together with the study of DNA hybridizations between phage DNAs permitted the distribution of all isolated phages in different unrelated groups. Although RFLP profiles were not performed with phages u111, u45, u79 and u81, the DNA homology studies allocate them among the group 1 of phages, together with phages: u135lar; u135sm; u38; u169; u68 and u39. The other unrelated phage groups are composed by the following phages: group 2 consists of phage u2 (variants a and b); group 3 consists of u4 ⁄ 1, uRBSc1 and uA1; group 4 consists of u12;, group 5 of u2 ⁄ 2 and a new group was created based on the DNA homology studies which comprises phages u31tu and uN5 (group 6).
Overall, of these different phage groups, only phages belonging to group 3 (u4 ⁄ 1) should not be used for phage therapy because of the homology with a number of bacterial strains and the hypothesis of having an input for defective prophages.
Dependence of growth of the selected phages from their last host
Considering this possibility, the host range of phages u68 (group 1) and u2 (group 2) was compared (see Table 3 ). To differentiate the origins of phage preparations, generally accepted designations were used. So, the stock of phage 'P' grown on bacterial strain 'S1' will be designated as 'P.S1'. Among the phages studied in this work, phage u2 may have special interest. Table 2 presents the results of the phage u2 growth characteristics which were propagated on different strains (905, 629B and 9510) and then tested on the set of all bacterial strains. As can be observed, all three variants of u2 preparations had slightly different effects on the set of bacteria used. The best results for phage u2 were obtained when grown on strain 905 where a clear plaque was observed in a higher number of strains (Table 3) .
The dependence of host range from the last host in which u68 was grown was also performed (Table 3 ). The differences obtained in this study were not as impressive as the ones obtained with the growth of u2 in distinct strains; however, it can be observed that phage u68's preferred hosts are equally strain Ex2 and 9510 (u68.Ex2 and u68.9510) .
Phage u68 grown using strain 932 failed to kill eight specific strains (see Table 3 ) that were susceptible to the phage grown on S. Enteritidis strains Ex2 and 9510.
Also, the effect of host dependence of phage Felix01 on three distinct hosts (821, 696 and Ex2) was compared (Table 3) . Felix01 grown on strains 821 and Ex2 was capable of forming plaques on almost all strains tested. Nevertheless, the lytic efficiency of Felix01 is clearly compromised when grown on different host susceptible strains. For instance, Felix01 growth on strain 696 made the phage no longer capable of infecting five isolates that the same phage grown on strain 821 succeeded to attack (Table 3) . CL, clear; no, no growth; r, presence of phage resistant colonies; tu, turbid; h, halo around the plaque; b, border of plaque; db, double border of plaque; mix, mixture of different types of clear and turbid plaques; mix1, mixture of turbid plaques; mix2, mixture of clear plaques; tr, traces of growth; -, no data; lar, large colony.
The lytic spectra of phages grown in different hosts also allowed to distinguish the bacterial isolates used, because the phage spot patterns on the bacterial lawns of the nine clusters, grouped according to their resistance patterns, varied greatly. A closer analysis of the lytic spectra data shows that all 31 tested hosts are different (Table 3) .
Overall, this work shows that to choose the right hosts for obtaining industrial quantities of phages, it is highly necessary to perform preliminary studies of restrictionmodification relations among the phages and their target bacterial strains.
Discussion
Phages are ubiquitous in nature and can be good candidates for use in animal therapy. This work shows that S. Enteritidis phages are readily isolated and worldwide distributed and can be efficient in killing bacterial isolates from different countries.
In this work, for phage isolation, a mixture of all nonlysogenic hosts was used and therefore it was assumed that single phage particles would find the most appropriate host in the first or subsequent cycles of growth. This strategy was adopted because the use of a single bacterial strain for enrichment not only may be too time consuming but can also lead to the loss of rare phages present in the sample because of the use of a 'wrong' first host. However, using all bacterial strains in a mixture makes difficult the identification of which bacterial strains were the last hosts for each phage. Consequently, some phages isolated from the initial plantings may present the same genotypes but may result in a variation in their phenotype because of the different host-induced modifications. Using comparisons of phage host ranges, performing growth on the same hosts or on several specially selected common hosts makes possible to differentiate potentially genotypically different phages and include them in further studies.
The phages studied here proved to belong to several different groups. The first group of phages gathers several closely related phages having genome sizes in the range of 32-38 kbp, sharing DNA homology and several common restrictional fragments (Fig. 1) . DNA isolated from preparation of phage u2, the second phage group, (Fig. 2a) had some homology with the DNAs of phages belonging to the first group. Nevertheless, it was possible that this preparation included an additional DNA-containing component.
The third phage group included phage u4 ⁄ 1 with a broad host range, having traces of homology with bacterial DNA. This last feature does not allow the use of such phages for the purpose of phage therapy.
Considering that these two phages, u2 and u4 ⁄ 1, and their respective variants which were obtained from the same bacterial host, the difference in the number and location of these additional bands (Fig. 2a) exclude their origination from bacterial DNA. The only possible explanation for this situation is that phages such as u2 and u4 ⁄ 1 can specifically induce different defective prophages in the same bacterial host. Based on the DNA homology experiments, phages uA1 and also uRBSc1 have homology to phage u4 ⁄ 1, and therefore these phages were grouped with this phage.
The fourth phage group includes phage u12 which has no DNA homology with other phages. It also may represent a phage complex (or mixture of two phages). Furthermore, this phage proved to be useful for the differentiation of bacterial strains. An interesting special feature of u12 was its great sensitivity to purification with CsCl because most of the restriction fragments, which were typically present in the total complex, disappeared in u12L. It can be concluded that the infecting phage u12 activates the development of a defective prophage whose DNA is being packed into the phage capsid. However, the defective prophage was not stable and disrupted in the course of CsCl treatment.
The fifth phage group comprises only phage u2 ⁄ 2. This phage has a large genome with nonequimolar restrictional fragments, a broad host range and no DNA homology with all other phages. The work described here suggests that the infection of both strains with phage u2 ⁄ 2 does not lead to activation of cryptic phage(s), or in the case that cryptic phage(s) are activated, they were not able to survive the CsCl gradient centrifugation.
From this study, it is evident that some of the strains used contain genes which could be packed into the phage capsids. These results confirm also previous studies performed with Salmonella sp. (Figueroa-Bossi et al. 1997; Schicklmaier et al. 1998; Schmieger 1999; Rabsch et al. 2002; Figueroa-Bossi and Bossi 2004; Mikasová et al. 2005; Kropinski et al. 2007) .
The broad host range phage u31tu showed DNA homology with uN5, and therefore these phages belong to group 6. Both phages were shown to have DNA resistant to digestion with EcoRI, EcoRV and HindIII.
The restriction-modification effects are very frequent in Salmonella sp. Thus, in this study, it was necessary to work with plenty of unstudied natural bacterial isolates and different newly isolated phages to know the possible effects of phage movements throughout the different hosts and their consequences in sense of their influence on phage activity through possible DNA modifications. The second important reason to check the 'effect of the last host' is because Salmonella genomes are known to carry plenty of different live and ⁄ or defective (cryptic) prophages (Figueroa-Bossi et al. 1997; Schicklmaier et al. 1998; Schmieger 1999; Rabsch et al. 2002; Figueroa-Bossi and Bossi 2004; Mikasová et al. 2005; Kropinski et al. 2007) . Therefore, recombination studies of infection with such phages or transactivation of such phage by any mechanism can result in a change of the genetic composition of the phage preparation and consequent influence on its final antibacterial activity. Furthermore, the host range of the different selected bacteriophages (and their possible relation in the phage grouping attribution) may be interesting for the use of veterinary phage therapy.
Interestingly, in this work, it was observed a change of the lysis spots into absolutely different ones because of growth of phages in different hosts, which consequently altered their lytic spectrum of activity. To exemplify the importance of the last host and the effect of phage growth on the phage plaque, a short example will be illustrated. So, for instance, a droplet of phage u2.629B placed on the lawn of strain Salmonella 9510 formed a highly transparent spot of lysis with a halo around the plaque while a droplet of u2.9510 placed on strain 9510 formed a plaque with a number of resistant colonies. The material from this spot, now called u2.629B.9510, when plated (after chloroform treatment) on the same fresh lawn of strain 9510, resulted in an absolutely different lysis spot that was extremely turbid and filled with phage-resistant cells (data not shown). One possible explanation for the transformation of, for instance, highly transparent spots with few resistant colonies, into very turbid spots filled with phage-resistant cells, as observed in the phage u2 growth experiments, might be the trans-activation effect of a defective phage (or bacteriocin) present in this case in the strain of 629B when the strains was infected. This defective helper phage will most likely kill bacterial mutants of strain 9510 that were resistant to u2; however, this helper phage seemed to disappear as it had no capability to replicate by itself. This phenomenon explains the high transparency of the lysis spot and presence of a small number of resistant colonies. The material taken from the spot formed on strain 9510 with phage u2.629B does not contain the active killer substance ⁄ additional defective phage that was activated in strain 629B, and the Salmonella 9510 strain did not have such transactivated parts in its genome. So, this work shows that the plaque differences obtained because of the last host where phage u2 was grown may depend on the transactivation of any cryptic phage and the consequent package of additional DNAs in the phage capsids and also on a modification activity of the last host. Nevertheless, these results clearly depend on the last bacterial growth host of phage u2. Consequently, in the final phage lysate, it is most likely that there are occurring two different killing activities. According to published results, bacteriophages of S. Enteritidis belong to several groups: P27-like (phage ST64B), P2-like (Fels-2, SopEphi, and PSP3), lambdoid (Gifsy-1, Gifsy-2, and Fels-1), P22-like (epsilon34, ES18, P22, ST104 and ST64T), T7-like (SP6) and three outliers (epsilon15, KS7 and Felix O1) (Kropinski et al. 2007 ). Thus, the most frequent prophage components in Salmonella are different derivatives of P22 or lambda-like phages. The second phage in a mixed lysate of u2 cannot be multiplied by itself but it can kill bacterial mutants resistant to u2 (low number of phage-resistant colonies to u2 preparation). Thus, it is possible that the cryptic phage genome belongs to a virulent phage, because the capability to kill bacteria just with adsorption of tail structure is typical for genuine virulent phages (as an example killing activity of T2 ghosts) (Herriott and Barlow 1957) or action of tail-like R2 bacteriocin of Pseudomonas aeruginosa (Nakayama et al. 2008) . The use of such phenomenon to increase the activity of phage mixtures can be promising and advantageous in an industrial scale production: contributing to a more economic way (as less phages will be necessary to obtain), saving other phages for future use and the possibility to use phages giving a high proportion of phage-resistant cells.
In conclusion, this work shows that the bacterial hosts need to be specially selected for each phage. Despite evidence shown that the used bacterial strains did not produce viable phages, we have confirmed that some phages, when grown on particular hosts, behave as complexes of phages. Thus, any change of the bacterial host used for maintenance of phages can drastically change the parameters of the phage preparations, including host range and lytic activity. This fact suggests that the use of phages as prophylactic agents against Salm. Enteritidis should be avoided to limit the massive disseminations of phages into natural habitats. Most importantly, the use of phages should be restricted to therapeutic purposes.
